The human integrin β4B and β4C variants are not expressed in a tissue-specific manner  by Micheloni, Alessia et al.
Correspondence
The human integrin L4B and L4C
variants are not expressed in
a tissue-speci¢c manner
Alessia Michelonia, Rita Falcionib, Giovanna Zambrunoa,
Marina D’Alessioa ;
First published online 29 April 2002
Integrins are a large family of heterodimeric cell surface
receptors that mediate cell^matrix interactions in important
biological processes, such as embryonic development, wound
healing, tissue di¡erentiation, and tumor progression [1]. It is
common knowledge that integrin K6L4 is unique among the
known integrin molecules. It concentrates in hemidesmosomes,
the speci¢c cell surface attachment sites for the keratin ¢la-
ment network in strati¢ed and complex epithelia. Moreover, in
contrast to all the other K and L subunit cytoplasmic domains,
the intracellular portion of the L4 subunit is unusually long. It
measures over 1000 amino acids in length and contains in its
C-terminal half two pairs of type III ¢bronectin-like repeats
separated by a 142 amino acid connecting segment [2].
In the last decade, a number of studies have reported that
the cytoplasmic domain of the integrin L4 subunit mediates
both the association with the hemidesmosomal cytoskeleton
and the recruitment of signaling adapter proteins participating
in signal transduction processes essential for proper cell cycle
control. Furthermore, it has been demonstrated that the L4
integrin subunit is highly expressed in some tumor cells, and
that this increased expression correlates with metastatic po-
tential of tumor cells [3]. Since the ¢rst publication of a partial
amino acid sequence of the integrin L4 subunit, a number of
di¡erent variants have been described [1]. Some of them are
known to be generated by proteolytic processing of the ma-
ture form of the L4 polypeptide, while others have been as-
cribed to tissue-speci¢c alternative splicing processes of a pre-
mRNA generated by a single copy gene [1]. As to the L4 chain
cytoplasmic domain, in addition to the primary most abun-
dant form L4A, a number of variants have been described in
humans. Two of them, L4B and L4C, contain in the connect-
ing segment inserts of 53 and 70 amino acids, respectively,
which are encoded by distinct exons. Moreover, a L4D variant
with a 21 bp deletion, generated by the use of a cryptic splice
site within intron 38, and a L4E form with a cytoplasmic
domain of only 232 amino acids, generated by retention of
intronic sequences that results in a frameshift and introduc-
tion of a premature termination codon, have been reported
[1]. Like most integrin subunits, the L4 splice variants are
always expressed together with the original L4A form. The
L4B splice variant, at ¢rst isolated from a human keratinocyte
cDNA library [2], has also been found by RT-PCR in human
placenta and peripheral nerves, as well as in mouse spleen,
while the L4C form has been detected exclusively in colon
and pancreatic carcinoma cell lines [1]. These ¢ndings sug-
gested that the preferential expression of the cytoplasmic var-
iants of the L4 chain could be ascribed to di¡erent L4 integrin
roles in various physiological and pathological conditions.
However, in vitro transfection experiments demonstrated
that the L4A and the L4B variants are similar in their ability
to associate with other hemidesmosomal components, to co-
localize with them in hemidesmosome-like structures and to
initiate the formation of hemidesmosomes in L4-de¢cient ker-
atinocytes [4]. To address still unresolved questions about the
biological signi¢cance of the L4B and L4C splice variants of
integrin L4, we evaluated their quantities in various tissue
samples. In a preliminary experiment, the transcription level
of the L4 integrin gene in di¡erent human normal tissues,
cultured primary cell types, and carcinoma cell lines was esti-
mated by dot blot analysis. Using a cDNA probe that recog-
nizes all cytoplasmic splice variants, in normal human kerati-
nocytes and human colon carcinoma cells fairly similar
amounts of L4 integrin mRNA were evidenced. By contrast,
kidney, placenta, non-small cell lung carcinoma and human
umbilical vein endothelial cells exhibited a signi¢cantly lower
expression level of L4 mRNA (Fig. 1a). Subsequently, using
the most sensitive RNase protection assay analysis, we as-
sessed the relative amount of the L4A, L4B and L4C splice
variants in the same tissue samples. As shown in Fig. 1b,c, the
use of speci¢c riboprobes revealed the presence of the L4A,
and to a much lesser extent, of the L4B and L4C splice var-
iants in HUVEC (human umbilical vein endothelial cells),
H1264 (non-small cell lung carcinoma cells), DLD1 (human
colon carcinoma cells), NHK (normal human keratinocytes),
human kidney and placenta. Quantitative densitometry of the
hybridization signals con¢rmed that most of the L4 integrin
mRNA encodes the L4A variant and that the L4B and L4C
forms represent a minimal amount (less than 2%) in all tis-
sues/cell types analyzed. Similar results were also obtained
with colon carcinoma CBS, GEO, and MIP, mammary carci-
noma BT474, squamous carcinoma A431, and lung carcinoma
CALU1 cell lines (not shown).
To our knowledge, these results indicate for the ¢rst time
the presence of both L4B and L4C integrin variants at con-
stant ratio in all human tissues analyzed, aside from the tran-
scription level of the L4 integrin mRNA. These data argue
against the hypothesized involvement of the cytoplasmic var-
iants of the L4 chain in conferring di¡erent functional roles to
the K6L4 heterodimer in distinct cell types. The very low tran-
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Table 1
Analysis of the RNA splice junction sequence surrounding the exons encoding the L4B and L4C splice variant insertions and evaluation of the
matching score to the consensus
5P sequence Score (%) 3P sequence Score (%)
Human exon 33 AGgtgaca 73.82 cgttgttcccaagG 80.09
Human exon 35 AGgtagta 69.16 tgtcctgccctagG 81.63
Mean of the ITGB4gene splice junctions 83.11J 5.1 86.47J 3.52
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scription level of the L4B and L4C variants suggests that these
variants might result from cellular missplicing events, rather
than from alternative splicing processes engendering to func-
tional isoforms. Since during pre-mRNA splicing processes
exon recognition is strictly dependent on sequence elements
residing in the immediate vicinity of the exon^intron borders,
analysis of the intronic sequences surrounding the two exons
encoding the 53 and the 70 amino acids insertions of the L4B
and L4C variants in human L4 integrin gene (GenBank
Y11107) was carried out. As summarized in Table 1, the
matching score of the splicing sequences to the consensus,
calculated according to the formula proposed by Shapiro
and Senapathy [5], is considerably lower for both exons com-
pared to the mean value of the entire ITGB4 gene.
In conclusion, taking into account the almost undetectable
level of both L4B and L4C splice variants in all tissues analyzed
and the consensus sequence analysis data, we speculate that
the L4B and L4C splice variants result from aberrant splicing
events occurring at constant ratios. To this end it is worth
mentioning that, despite the relatively high number of genetic
mutations characterized in the human integrin L4 subunit gene
[6], no mutations have so far been identi¢ed in the exonic
sequences encoding the 53 and 70 amino acid insertions.
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Fig. 1. Evaluation of the human integrin L4 transcription level and
quanti¢cation of the L4A, L4B and L4C splice variants in di¡erent
human normal tissues, cultured primary cell types, and carcinoma
cell lines. a: Total RNA (1 Wg) from di¡erent tissues and cultured
cells was transferred onto Hybond N nylon membranes (Amersham
International, Little Chalfont, UK) using a dot blot apparatus. The
membranes were hybridized in QuikHyb hybridization solution (Stra-
tagene, Cedar Creek, TX, USA) with a 32P-labeled L4 integrin
cDNA probe encompassing nucleotides 34^665, which recognizes all
splice variants. Filters were washed following the manufacturer’s in-
structions and exposed for autoradiography (top). For loading con-
trol, hybridization with a 32P-labeled L-actin cDNA probe was car-
ried out (bottom). Quanti¢cation of the hybridization signals was
performed by densitometric scanning using a GS-750 densitometer
(Bio-Rad, Hercules, CA, USA). b,c: Total RNAs (10 Wg) from dif-
ferent sources were tested by RNase protection assays. To generate
the L4B-speci¢c riboprobe, the following oligonucleotide primers,
forward 5P-CGAGACTCTATAATCCTGGC-3P and reverse 5P-GGT-
GCACCTGGGATTCAA-3P, were used to amplify from normal hu-
man keratinocyte cDNA a 363 bp fragment encompassing the last
52 bp of exon 35, exon 36 and 162 bp of exon 37 of the L4 integrin
subunit coding sequence (GenBank Y11107). The PCR fragment, in-
serted in the dual promoter pCR II Topo plasmid vector (Invitrogen,
San Diego, CA, USA), was subjected to retro-transcription using the
Sp6 and T7 RNA polymerase (Promega, Madison, WI, USA). The
antisense product obtained makes it possible to discriminate between
the L4A and the L4B splice variants (311 bp and 363 bp, respec-
tively). The L4C mRNA was evidenced by using the following oligo-
nucleotide primers, forward 5P-GACCTATTGGGCCCATGAAG-3P
and reverse 5P-AGGTCCAGCTCCTCCCCCAG-3P, which amplify
from normal human keratinocyte cDNA a speci¢c 361 bp fragment
encompassing exons 31, 32 and the ¢rst 46 bp of exon 33 of the L4
coding sequence. The RNA probe, generated by transcription of the
PCR-cloned fragment, allows discrimination between the L4A and
the L4C splice variants (315 bp and 361 bp, respectively). The length
of the protected RNA bands was estimated using radiolabeled RNA
molecular weight markers (Roche Diagnostic, Monza, Italy). In or-
der to obtain a detectable amount of the minor splice variants in all
cell lines/tissues analyzed, loading of the RNase protection assays
products was performed utilizing an equivalent amount of radioactiv-
ity incorporated. b: Top panel, hybridization signals of L4B variant;
bottom panel, hybridization signals of the L4A form. c: Top panel,
hybridization signals of L4C variant; bottom panel, hybridization
signals of the L4A form. Evaluation of the relative amount of the L4
mRNA isoforms was performed by densitometric analysis. The
RNAs utilized were from: HUVEC (lane 1), H1264 (lane 2), DLD1
(lane 3) (kindly provided by Fiorella Guadagni and Carol J. Thiele,
respectively), NHK (lane 4), human kidney and placenta (lanes 5, 6)
(Clontech Laboratories, Palo Alto, CA, USA). As negative control,
human ¢broblast total RNA (lane 7) and yeast tRNA (lane C) were
used. HUVEC were isolated according to standard protocols, and
cultured on ¢bronectin (Sigma-Aldrich, St. Louis, MO, USA)-coated
plates in RPMI 1640 medium supplemented with 10% fetal bovine
serum, 50 Wg/ml ECGS, 100 Wg/ml heparin and 2 mM L-glutamine.
H1264 and DLD1 cell lines were cultured in RPMI 1640, supple-
mented with 10% fetal calf serum. Primary cultures of normal hu-
man keratinocytes were established using standard procedures. Total
RNA was extracted by lysis of the cell cultures in the presence of
guanidine isothiocyanate using standard protocols.
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